Do COX-2 inhibitors really prevent hypertension and proteinuria? Another brick in the wall for the COX-2 inhibition and cardiovascular disease controversy

J Hypertens. 2003 Mar;21(3):501-3. doi: 10.1097/00004872-200303000-00013.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / pharmacology*
  • Humans
  • Hypertension / prevention & control*
  • Isoenzymes / antagonists & inhibitors*
  • Membrane Proteins
  • NG-Nitroarginine Methyl Ester / toxicity
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide / deficiency
  • Prostaglandin-Endoperoxide Synthases
  • Proteinuria / prevention & control*
  • Rats

Substances

  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • Nitric Oxide
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • NG-Nitroarginine Methyl Ester